CRIS - Strong Double BottomsRecurring Double Bottom patterns are evident
Once price completes its current double bottom 1.70 is a good target for price to aim for
CRIS
CRIS Trend Holding - More Upside To Come
About:
Curis, Inc. is a biotechnology company seeking to develop and commercialize drug candidates for the treatment of cancers. The Company's drug candidate is CUDC-907, an orally-available, small molecule inhibitor of histone deacetylase (HDAC) and phosphatidylinositol-3-kinase (PI3K) enzymes. CUDC-907 is an oral, dual inhibitor of Class I and II HDAC, as well as Class I PI3K enzymes. CA-170 is an oral small molecule drug candidate that is designed to selectively target programmed death ligand-1 (PDL1) and V-domain Ig suppressor of T-cell activation (VISTA) immune checkpoint proteins, both of which independently function as negative regulators of immune activation. CA-4948 is an oral small molecule drug candidate that is designed to inhibit the Interleukin-1 receptor-associated kinase 4 (IRAK4) kinase, which is a transducer of toll-like receptor or certain interleukin receptor signaling pathways.
SHORT INTEREST
453.34K 06/28/19
P/E Ratio (with extraordinary items)
-2.40
Further Information:
Each of the Q3 2019 Inducement Grants has an exercise price per share equal to the closing price of the Company's common stock on July 1, 2019. Each stock option has a 10 year term and vests over four years, with 25% of the original number of shares underlying the award vesting on the first anniversary of the employee's date of hire and an additional 6.25% of the original number of shares underlying the award vesting on each successive three-month period thereafter, subject to the employee's continued service with the Company through the respective vesting dates. Each stock option was granted as an inducement equity award outside of the Company's Third Amended and Restated 2010 Stock Incentive Plan and was made as an inducement material to the employee's acceptance of employment with the Company.
CRIS HAS BROKEN THE DAILY DOWNTRENDCRIS has broken the daily downtrend with a strong impulse. I'm looking for a pullback, one more wave up and a big drop. Look to the price action for more details.
